Emergent autoimmunity in graft-versus-host disease
- PMID: 15746077
- PMCID: PMC1894995
- DOI: 10.1182/blood-2004-12-4980
Emergent autoimmunity in graft-versus-host disease
Abstract
Donor T-cell recognition of host alloantigens presented by host antigen-presenting cells (APCs) is necessary for the induction of graft-versus-host disease (GVHD), but whether direct alloreactivity is sufficient for the propagation of GVHD is unknown. In this study, we demonstrate that GVHD cannot be effectively propagated through the direct pathway of allorecognition. Rather, donor T-cell recognition of antigens through the indirect pathway is necessary for the perpetuation of GVHD. Furthermore, GVHD results in the breaking of self tolerance, resulting in the emergence of donor T cells that can cause autoimmune disease in syngeneic recipients. Notably, GVHD-induced autoreactivity is donor APC dependent, transferable into secondary hosts, and involves cells of the innate immune system. These results indicate that donor T-cell--mediated pathologic damage during GVHD becomes donor APC dependent and provide a mechanistic explanation for the long-standing observation that GVHD is associated with autoimmune clinical manifestations.
Figures






Similar articles
-
Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.Anat Rec (Hoboken). 2019 May;302(5):825-836. doi: 10.1002/ar.23972. Epub 2018 Nov 25. Anat Rec (Hoboken). 2019. PMID: 30312018
-
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.Blood. 2005 Mar 1;105(5):2227-34. doi: 10.1182/blood-2004-08-3032. Epub 2004 Nov 2. Blood. 2005. PMID: 15522961
-
Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.Biol Blood Marrow Transplant. 1999;5(4):222-30. doi: 10.1053/bbmt.1999.v5.pm10465102. Biol Blood Marrow Transplant. 1999. PMID: 10465102
-
Modulation of graft-versus-host disease: role of regulatory T lymphocytes.Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):13-21. doi: 10.1016/j.bbmt.2005.11.002. Biol Blood Marrow Transplant. 2006. PMID: 16399597 Review.
-
Understanding the alloresponse: new approaches to graft-versus-host disease prevention.Semin Hematol. 2002 Jan;39(1):15-22. doi: 10.1053/shem.2002.29246. Semin Hematol. 2002. PMID: 11799525 Review.
Cited by
-
The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Immunol Res. 2013 Dec;57(1-3):125-39. doi: 10.1007/s12026-013-8450-7. Immunol Res. 2013. PMID: 24272856 Free PMC article. Review.
-
Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation.F1000Res. 2016 Jun 27;5:F1000 Faculty Rev-1510. doi: 10.12688/f1000research.8118.1. eCollection 2016. F1000Res. 2016. PMID: 27408705 Free PMC article. Review.
-
Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Front Immunol. 2015 Jan 28;6:14. doi: 10.3389/fimmu.2015.00014. eCollection 2015. Front Immunol. 2015. PMID: 25674088 Free PMC article. Review.
-
Graft-versus-host disease therapy: something else beyond glucocorticoids?Haematologica. 2011 Sep;96(9):1249-51. doi: 10.3324/haematol.2011.050534. Haematologica. 2011. PMID: 21880641 Free PMC article. No abstract available.
-
B cells in chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2015 Jan;21(1):16-23. doi: 10.1016/j.bbmt.2014.10.029. Epub 2014 Nov 12. Biol Blood Marrow Transplant. 2015. PMID: 25452031 Free PMC article. Review.
References
-
- Ferrara JLM, Deeg HJ, Burakoff S. Graft versus host disease. New York: Marcell Dekker, 1997.
-
- Reddy P. Pathophysiology of acute graft-versus-host disease. Hematol Oncol. 2003;21: 149-161. - PubMed
-
- Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol. 2004;125: 435-454. - PubMed
-
- Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation. 1988;46: 238-240. - PubMed
-
- Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol. 1987;66: 45-47. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous